By Professor Michael Proinsias Farrell

Conference Presentations

Hopkins R; Bharat C; Chambers M; Degenhardt L; Peacock A; Farrell M; Yuen WS; Man N; Gisev N, 2024, 'Age, period, and cohort trends of substance poisoning, alcohol-related disease, and suicide deaths in Australia, 1980-2019', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=vxBO7_cTwPU&t=554s

Sutherland R; Karlsson A; Uporova J; Chandrasena U; Price O; Chrzanowska A; Man N; Bruno R; Dietze P; Lenton S; Salom C; Degenhardt L; Farrell M; Peacock A, 2024, 'Emerging trends in drug use, harms, and markets: Findings from Drug Trends 2024', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=vxBO7_cTwPU&t=3941s

Foley C; Domberelli A; Seccull A; La Hera Fuentes G; Hedger D; Gill T; Jones P; Fox S; Collie P; Tyler V; Kerr N; Auld R; Bailey A; Stephens A; Stolk SS; Asare-Doku W; Izzard T; Doyle M; Farnbach S; Gates P; Farrell M, 2024, 'Greater than the sum of its parts: Establishing a base for collaborative research in regional NSW to improve drug and alcohol outcomes in rural, regional, and remote communities', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024

Weatherburn D; Rahman S; Todd S; Poynton S; Black S; Merinda T; Farrell M, 2024, 'The impact of the NSW MERIT diversion program reoffending, imprisonment, and health', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=7YQqzJTbdAs&t=1808s

Acheson L; Ezard N; Lintzeris N; Dunlop A; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried K, 2022, 'Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot safety and feasibility trial', presented at The 2022 APSAD Scientific Alcohol and Drugs Conference, Darwin, Australia, 09 October 2022 - 12 October 2022, https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.13537

Siefried K; Acheson L; Williams B; Farrell M; McKetin R; Ezard N, 2022, 'OUTCOMES AND MEASURES USED IN RANDOMISED CONTROLLED TRIALS EXAMINING PHARMACOTHERAPIES FOR THE TREATMENT OF METHAMPHETAMINE WITHDRAWAL: RESULTS OF A SYSTEMATIC REVIEW', presented at The College on Problems of Drug Dependence 84th Annual Scientific Meeting, Minneapolis, USA, 11 June 2022 - 15 July 2022, https://d2p55c5k0gw6a2.cloudfront.net/wp-content/uploads/2022/07/2022-CPDD-Abstract-Book.pdf

Siefried K; Arunogiri S; Brett J; McKetin R; Acheson LS; Knock E; Farrell M; Dunlop A; Lintzeris N; Ezard N, 2021, 'The future of pharmacotherapy clinical trials in Australia: the OLAM trial; the MOXY trial; the PSIMA trial; the TINA trial', presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Larance B; Peacock A; Campbell G; Freckleton S; Smith K; Mattick R; Bruno R; Nielsen S; Cohen M; Lintzeris N; Shand F; Hall WD; Farrell M; Degenhardt L; Peacock A, 2014, 'ALCOHOL USE DISORDERS, RISKY ALCOHOL CONSUMPTION AND ADVERSE EVENTS AMONG CHRONIC NON-CANCER PAIN PATIENTS RECEIVING OPIOID THERAPY'

Campbell G; Mattick R; Bruno R; Larance B; Nielsen S; Cohen M; Lintzeris N; Shand F; Hall WD; Farrell M; Degenhardt L, 2014, 'CHARACTERISTICS OF A NATIONAL SAMPLE OF PEOPLE WITH CHRONIC NON-CANCER PAIN PRESCRIBED PRESCRIPTION OPIOIDS'

Larance B; Nielsen S; Hordern A; Lintzeris N; Burns L; Mattick R; Campbell G; Farrell M; Cohen M; Bruno R; Brown A; Johnson J; Degenhardt L, 2014, 'PHARMACEUTICAL OPIOID USE AND PAIN AMONG PEOPLE WHO INJECT DRUGS: BASELINE FINDINGS FROM A PROSPECTIVE COHORT STUDY'

Nielsen S; Larance B; Lintzeris N; Holliday S; Vanderhaven M; Hordern A; Dunlop A; Haber P; Murnion B; Silsbury C; Johnson J; Demirkol A; Sadler C; Phung N; Burns L; Mattick R; Campbell G; Farrell M; Cohen M; Bruno R; Hardy M; Brown A; Houseman J; Degenhardt L, 2014, 'SEEKING TREATMENT FOR PHARMACEUTICAL OPIOID DEPENDENCE: BASELINE CHARACTERISTICS FROM AN IN-TREATMENT COHORT'

Back to profile page